1. Home
  2. PROK vs ONIT Comparison

PROK vs ONIT Comparison

Compare PROK & ONIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • ONIT
  • Stock Information
  • Founded
  • PROK 2015
  • ONIT 1988
  • Country
  • PROK United States
  • ONIT United States
  • Employees
  • PROK N/A
  • ONIT N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • ONIT
  • Sector
  • PROK Health Care
  • ONIT
  • Exchange
  • PROK Nasdaq
  • ONIT NYSE
  • Market Cap
  • PROK 237.4M
  • ONIT 236.4M
  • IPO Year
  • PROK N/A
  • ONIT 1996
  • Fundamental
  • Price
  • PROK $1.54
  • ONIT $31.63
  • Analyst Decision
  • PROK Buy
  • ONIT Buy
  • Analyst Count
  • PROK 5
  • ONIT 1
  • Target Price
  • PROK $4.50
  • ONIT $45.00
  • AVG Volume (30 Days)
  • PROK 410.1K
  • ONIT 39.5K
  • Earning Date
  • PROK 11-12-2024
  • ONIT 11-05-2024
  • Dividend Yield
  • PROK N/A
  • ONIT N/A
  • EPS Growth
  • PROK N/A
  • ONIT N/A
  • EPS
  • PROK N/A
  • ONIT 1.83
  • Revenue
  • PROK N/A
  • ONIT $1,028,500,000.00
  • Revenue This Year
  • PROK N/A
  • ONIT N/A
  • Revenue Next Year
  • PROK N/A
  • ONIT $4.06
  • P/E Ratio
  • PROK N/A
  • ONIT $18.25
  • Revenue Growth
  • PROK N/A
  • ONIT N/A
  • 52 Week Low
  • PROK $1.18
  • ONIT $22.40
  • 52 Week High
  • PROK $4.44
  • ONIT $36.91
  • Technical
  • Relative Strength Index (RSI)
  • PROK 37.52
  • ONIT 46.17
  • Support Level
  • PROK $1.70
  • ONIT $32.51
  • Resistance Level
  • PROK $2.03
  • ONIT $34.40
  • Average True Range (ATR)
  • PROK 0.21
  • ONIT 1.19
  • MACD
  • PROK -0.04
  • ONIT -0.00
  • Stochastic Oscillator
  • PROK 0.74
  • ONIT 28.54

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

About ONIT ONITY GROUP INC

Onity Group Inc is a leading non-bank mortgage servicer and originator providing solutions through its primary brands, PHH Mortgage and Liberty Reverse Mortgage. PHH Mortgage is one of the largest servicers in the country, focused on delivering a variety of servicing and lending programs. Liberty is one of the nation's largest reverse mortgage lenders dedicated to education and providing loans that help customers meet their personal and financial needs.

Share on Social Networks: